Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAlterity Therapeutics Limited Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
Alterity Therapeutics Limited Earnings Date And Information
Alterity Therapeutics Limited last posted its earnings results on Thursday, February 27th, 2025. The company reported $-0.43529 earnings per share for the quarter, topping analysts' consensus estimates of $-0.53335 by $0.09806. The company had revenue of 2.12 M for the quarter and had revenue of 4.02 M for the year. Alterity Therapeutics Limited has generated $0 earnings per share over the last year ($-0.0052 diluted earnings per share) and currently has a price-to-earnings ratio of -2.97. Alterity Therapeutics Limited has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, February 3rd, 2025 based on prior year's report dates.
Alterity Therapeutics Limited Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 06/28/2024 | Q4 2024 | N/A | -$0.00 | N/A | N/A | $2.12 M |
| 12/29/2023 | Q2 2024 | N/A | -$0.00 | N/A | N/A | $1.90 M |
| 06/29/2023 | Q4 2023 | N/A | -$0.00 | N/A | N/A | $1.53 M |
| 12/30/2022 | Q2 2023 | N/A | -$0.00 | N/A | N/A | $2.39 M |
| 06/29/2022 | Q4 2022 | N/A | -$0.00 | N/A | N/A | $2.76 M |
| 12/30/2021 | Q2 2022 | N/A | -$0.00 | N/A | N/A | $2.36 M |
| 06/29/2021 | Q4 2021 | N/A | -$0.00 | N/A | N/A | $2.46 M |
| 12/30/2020 | Q2 2021 | N/A | -$0.01 | N/A | N/A | $1.88 M |
| 06/30/2020 | Q4 2020 | N/A | -$0.01 | N/A | N/A | $-1,855,172 |
| 12/31/2019 | Q2 2020 | N/A | -$0.01 | N/A | N/A | $1.86 M |
| 06/30/2019 | Q4 2019 | N/A | -$0.01 | N/A | N/A | $2.52 M |
| 12/30/2018 | Q2 2019 | N/A | -$0.01 | N/A | N/A | $2.43 M |
| 06/29/2018 | Q4 2018 | N/A | -$0.01 | N/A | N/A | $1.65 M |
| 12/30/2017 | Q2 2018 | N/A | -$0.01 | N/A | N/A | $1.48 M |
| 06/29/2017 | Q4 2017 | N/A | -$0.01 | N/A | N/A | $1.25 M |
| 12/30/2016 | Q2 2017 | N/A | -$0.01 | N/A | N/A | $1.90 M |
| 06/29/2016 | Q4 2016 | N/A | -$0.01 | N/A | N/A | $2.04 M |
| 12/30/2015 | Q2 2016 | N/A | -$0.01 | N/A | N/A | $2.86 M |
| 06/29/2015 | Q4 2015 | N/A | -$0.01 | N/A | N/A | $3.07 M |
| 12/30/2014 | Q2 2015 | N/A | -$0.00 | N/A | N/A | $3.42 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Alterity Therapeutics Limited Earnings: FAQ's
Alterity Therapeutics Limited has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, February 3rd, 2025 based offlast year's report dates.
In the previous quarter, Alterity Therapeutics Limited (:ATHE) reported $-0.43529 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.53335 by $0.09806.
The conference call for Alterity Therapeutics Limited's latest earnings report can be listened to online.
The conference call transcript for Alterity Therapeutics Limited's latest earnings report can be read online.
Alterity Therapeutics Limited (:ATHE) has a recorded annual revenue of $4.02 M.
Alterity Therapeutics Limited (:ATHE) has a recorded net income of $-19,123,464.Alterity Therapeutics Limited has generated $-0.0052 earnings per share over the last four quarters.
Alterity Therapeutics Limited (:ATHE) has a price-to-earnings ratio of -2.97 and price/earnings-to-growth ratio is -0.37.